Vitamin B3 shows promise for glaucoma patients in world-first clinical trial
A world-first clinical trial led by the Centre for Eye Research Australia has shown that vitamin B3 (nicotinamide) could play an important role in protecting[…]
Read more »
COVID-19: Keeping our trial patients safe
Our clinical researchers are adhering to strict hygiene and physical distancing protocols while delivering sight saving treatments to patients who are part of our clinical[…]
Read more »
Meet the frontline eye bank workers helping to save sight during COVID-19
Things look a little different for the Lions Eye Donation Service during the challenging times of COVID-19, but the eye bank is as busy as[…]
Read more »
Don’t risk your vision in COVID-19 lockdown
Leading macular researcher Professor Robyn Guymer AM is urging patients with age-related macular degeneration not to risk their sight by delaying essential treatment because of[…]
Read more »
Using artificial intelligence for early detection of keratoconus
CERA researchers are investigating the use of artificial intelligence to help detect signs of keratoconus, thanks to new funding from the Perpetual 2020 IMPACT Philanthropy[…]
Read more »
AI research to prevent vision loss and tackle cardiovascular disease
Australian researchers have won major funding to develop an artificial intelligence powered eye scan which can screen patients for risk of blinding eye diseases, heart[…]
Read more »
